Search - tctmd.com

Displaying 61 - 80 of 258

Sort: Relevancy | Date

Evoque and Patisiran: A Tale of Two Regulatory Journeys

News Opinion Off Script

Evoque and Patisiran: A Tale of Two Regulatory Journeys

Sanjay Kaul, MD

March 29, 2024

ICD Benefits Hold Up for Modern-day Primary Prevention, but Questions Remain

News Daily News

ICD Benefits Hold Up for Modern-day Primary Prevention, but Questions Remain

March 25, 2024

How Meaningful Are Heart Failure Hospitalizations in Today’s RCTs?

News Daily News

How Meaningful Are Heart Failure Hospitalizations in Today’s RCTs?

March 07, 2024

Durable 1-Year Outcomes With Coronary Sinus Shunt for HF: ALT-FLOW EFS

News Conference News THT 2024

Durable 1-Year Outcomes With Coronary Sinus Shunt for HF: ALT-FLOW EFS

Michael O'Riordan

March 06, 2024

Future HF Trials Should Focus on Patients in the High-Risk Period After an ADHF Hospitalization

Presentation THT 2024

Future HF Trials Should Focus on Patients in the High-Risk Period After an ADHF Hospitalization

Presenter: Gad Cotter

March 04, 2024

The Future of Heart Failure Trials: Faster, Better and More Efficient Approaches to Approvals

Presentation THT 2024

The Future of Heart Failure Trials: Faster, Better and More Efficient Approaches to Approvals

Presenter: Scott Solomon

March 04, 2024

FDA-Approved But Less Frequently Used Device Therapies to Treat HFrEF: Challenges and Opportunities

Presentation THT 2024

FDA-Approved But Less Frequently Used Device Therapies to Treat HFrEF: Challenges and Opportunities

Presenter: Michael R. Zile

March 04, 2024

New Approaches to Treating Heart Failure

Presentation THT 2024

New Approaches to Treating Heart Failure

Presenter: W. H. Wilson Tang

March 04, 2024

Living Near Bars, Restaurants Linked to Greater Likelihood of HF

News Daily News

Living Near Bars, Restaurants Linked to Greater Likelihood of HF

February 29, 2024

TriClip panel FDA

News Daily News

FDA Panel Takes a Positive View of TriClip in Tricuspid Regurgitation

Michael O'Riordan

February 13, 2024

More Mortality Reduction Signals With Implantable Hemodynamic Monitors in HFrEF: Meta-analysis

News Daily News

More Mortality Reduction Signals With Implantable Hemodynamic Monitors in HFrEF: Meta-analysis

February 12, 2024

Most Takotsubo Patients Die From CV Causes, but Standard Meds No Help

News Daily News

Most Takotsubo Patients Die From CV Causes, but Standard Meds No Help

January 11, 2024

January 2024 Dispatch for the CV Team

News Opinion CV Team Dispatch

January 2024 Dispatch for the CV Team

January 01, 2024

The Biggest News of 2023: TCTMD’s Top 10

News Opinion Editor's Corner

The Biggest News of 2023: TCTMD’s Top 10

January 01, 2024

Left Bundle Branch Area Pacing May Lessen Arrhythmias in CRT Patients

News Conference News AHA 2023

Left Bundle Branch Area Pacing May Lessen Arrhythmias in CRT Patients

November 15, 2023

DAPA-MI: Cardiometabolic Endpoints ‘Win’ With Dapagliflozin After Acute MI

News Conference News AHA 2023

DAPA-MI: Cardiometabolic Endpoints ‘Win’ With Dapagliflozin After Acute MI

November 11, 2023

Innovation in Heart Donation, Preservation Set to Shake Up Allocation

News Conference News HFSA 2023

Innovation in Heart Donation, Preservation Set to Shake Up Allocation

October 18, 2023

STRONG-HF Analysis: Safety Events Common but Manageable in GDMT Optimization

News Conference News HFSA 2023

STRONG-HF Analysis: Safety Events Common but Manageable in GDMT Optimization

October 18, 2023

ANTHEM-HFrEF Fails to Show Benefit of Vagal Nerve Stimulation Over GDMT

News Conference News HFSA 2023

ANTHEM-HFrEF Fails to Show Benefit of Vagal Nerve Stimulation Over GDMT

Yael L. Maxwell

October 16, 2023

REBALANCE-HF Uncovers HFpEF Group That Responds to Splanchnic Nerve Ablation

News Conference News HFSA 2023

REBALANCE-HF Uncovers HFpEF Group That Responds to Splanchnic Nerve Ablation

October 11, 2023

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.